verapamil has been researched along with Esophageal Neoplasms in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to investigate the reversal effect of verapamil (VER) on the chemoresistance to cisplatin of esophageal squamous cell carcinoma (ESCC) cells." | 8.02 | Upregulation of KCNMA1 facilitates the reversal effect of verapamil on the chemoresistance to cisplatin of esophageal squamous cell carcinoma cells. ( Chang, N; Fan, PS; Ge, N; Kang, YH; Yang, GS; Zhang, TY; Zhou, Q, 2021) |
| "This study aimed to investigate the reversal effect of verapamil (VER) on the chemoresistance to cisplatin of esophageal squamous cell carcinoma (ESCC) cells." | 4.02 | Upregulation of KCNMA1 facilitates the reversal effect of verapamil on the chemoresistance to cisplatin of esophageal squamous cell carcinoma cells. ( Chang, N; Fan, PS; Ge, N; Kang, YH; Yang, GS; Zhang, TY; Zhou, Q, 2021) |
| "Verapamil has been shown to reverse acquired drug resistance to Adriamycin (ADR) and vinblastine in the P388 leukemia and Ehrlich ascites carcinoma model systems." | 1.27 | Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells. ( Cox, TC; Crowley, J; Goodman, GE; Yen, YP, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, N | 1 |
| Yang, GS | 1 |
| Zhang, TY | 1 |
| Chang, N | 1 |
| Kang, YH | 1 |
| Zhou, Q | 1 |
| Fan, PS | 1 |
| Wang, Y | 1 |
| Chen, Q | 1 |
| Jin, S | 1 |
| Deng, W | 1 |
| Li, S | 1 |
| Tong, Q | 1 |
| Chen, Y | 1 |
| Haorah, J | 1 |
| Miller, DW | 1 |
| Brand, R | 1 |
| Smyrk, TC | 1 |
| Wang, X | 1 |
| Chen, SC | 1 |
| Mirvish, SS | 1 |
| Goodman, GE | 1 |
| Yen, YP | 1 |
| Cox, TC | 1 |
| Crowley, J | 1 |
4 other studies available for verapamil and Esophageal Neoplasms
| Article | Year |
|---|---|
Upregulation of KCNMA1 facilitates the reversal effect of verapamil on the chemoresistance to cisplatin of esophageal squamous cell carcinoma cells.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Survival; Cisplatin; Drug Re | 2021 |
Up-regulation of P-glycoprotein is involved in the increased paclitaxel resistance in human esophageal cancer radioresistant cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Ci | 2012 |
Diffusion of dialkylnitrosamines into the rat esophagus as a factor in esophageal carcinogenesis.
Topics: Animals; Calcium Channel Blockers; Carcinogens; Central Nervous System Depressants; Diffusion; Enzym | 1999 |
Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells.
Topics: Breast Neoplasms; Cell Survival; Clone Cells; Colonic Neoplasms; Doxorubicin; Drug Resistance; Esoph | 1987 |